Your SlideShare is downloading. ×
  • Like
Cancer Medicine and Hematology
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Cancer Medicine and Hematology

  • 149 views
Published

 

Published in Health & Medicine
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
149
On SlideShare
0
From Embeds
0
Number of Embeds
1

Actions

Shares
Downloads
4
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. cancer medicine and hematology Harvard Medical School Department of Continuing Education Earn up to 51.75 AMA PRA Crategory 1 Credits™ Sunday, September 29 - Friday, October 4, 2013 at the Fairmont Copley Plaza Hotel, Boston, MA under the direction of Robert J. Mayer, M.D.
  • 2. COURSE OVERVIEW The continuing deluge of new clinical data on novel cancer therapies, molecular diagnostics tests, and emerging treatment approaches makes it difficult for practicing oncologists to stay current and up-to-date on the rationale behind these advances. This intensive six-day activity is designed to provide a comprehensive review for practitioners of the clinical, molecular, and pathophysiologic basis for the diagnosis and treatment of neoplastic diseases and benign hematologic disorders. Primary emphasis will be placed upon the broad area of medical management. Recent advances in molecular genetics, clinical pharmacology, epidemiology, and supportive care will be stressed. Teaching will be primarily through lectures, panels, and case discussions with the assistance of appropriate visual aids. Participants will be invited to present challenging cases to a faculty panel in a special Wednesday evening session. Optional Maintenance of Certification (MOC) opportunity for optimum results! Attendees enrolled in ABIM’s Maintenance of Certification (MOC) course and required to earn points towards recertification may attend an optional MOC session on Tuesday evening. This session will guide you through the 2013 Update in Medical Oncology module. LEARNER OBJECTIVES After participating in this program, learners will be able to: • Evaluate, treat, and manage patients with hematologic disorders more effectively by making appropriate use of current and emerging therapies, cytological characteristics, and molecular diagnostics tests • Improve care for breast cancer patients by incorporating novel targeted therapies and molecular diagnostics testing into current treatment paradigms • Create multimodal treatment plans for lung, head, and neck cancers that utilize newly approved therapies and conform more closely to current expert recommendations • Improve treatment of patients with gastrointestinal and neuroendocrine cancers with more effective uses of molecular diagnostics and available systemic therapies • Provide care for prostate, testicular, renal, and bladder cancers that is tailored to individual patients and their risk factors and makes appropriate use of new and emerging therapie Sunday, September 29 - Friday, October 4, 2013 cancer medicine and hematology www.cme.hms.harvard.edu/courses/cancermedicine • Utilize genetic testing, novel treatment approaches, and palliative care to create optimized care plans for patients with ovarian, cervical, endometrial, and trophoblastic cancers • Incorporate new therapies where available and new clinical trial data into management plans for a wide range of less common cancers, including brain tumors, thyroid cancer, melanoma, sarcoma, and mesothelioma • Provide effective supportive and palliative care by actively managing pain, depression, dementia, emesis, insomnia, infection, and other aspects of cancer and cancer treatment that can detract from patient quality of life and produce less than optimal outcomes WHO SHOULD ATTEND Medical Oncologists, Hematologists, Radiation Oncologists, Oncology Surgeons, and Internists ACGME COMPETENCIES This course is designed to meet one or more of the following Accreditation Council of Graduate Medical Education competencies: • Patient Care • Medical knowledge • Practice-based learning and improvement and Interpersonal and communication skills ACCREDITATION The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Harvard Medical School designates this live activity for a maximum of 51.75 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 0.75 credits of Risk Management Study. This includes: 0.75 Credits of Opioid Education and Pain Management Training.
  • 3. Janet L. Abrahm, M.D. Dana-Farber Cancer Institute Jeremy S. Abramson, M.D. Massachusetts General Hospital Kenneth C. Anderson, M.D. Dana-Farber Cancer Institute Tracy T. Batchelor, M.D., M.P.H. Massachusetts General Hospital Kenneth A. Bauer, M.D. Beth Israel Deaconess Medicine Center Edward J. Benz, Jr., M.D. Dana-Farber Cancer Institute Robert A. Brodsky, M.D. Johns Hopkins University Harold J. Burstein, M.D., Ph.D. Dana-Farber Cancer Institute John C. Byrd, M.D. Ohio State University George P. Canellos, M.D. Dana-Farber Cancer Institute Stephen A. Cannistra, M.D. Beth Israel Deaconess Medical Center Toni K. Choueiri, M.D. Dana-Farber Cancer Institute Jean M. Connors, M.D. Brigham and Women’s Hospital Gilbert Daniels, M.D. Massachusetts General Hospital Daniel J. DeAngelo, M.D., Ph.D. Dana-Farber Cancer Institute George D. Demetri, M.D. Dana-Farber Cancer Institute Walter H. Dzik, M.D. Massachusetts General Hospital Mark D. Fleming, M.D., D.Phil. Boston Children’s Hospital Arnold S. Freedman, M.D. Dana-Farber Cancer Institute Charles S. Fuchs, M.D., M.P.H. Dana-Farber Cancer Institute Judy E. Garber, M.D., M.P.H. Dana-Farber Cancer Institute Levi A.Garraway, M.D., Ph.D Dana-Farber Cancer Institute James D. Griffin, M.D. Dana-Farber Cancer Institute Robert I. Haddad, M.D. Dana-Farber Cancer Institute Robert I. Handin, M.D. Brigham and Women’s Hospital Matthew M. Heeney, M.D. Boston Children’s Hospital F. Stephen Hodi, M.D. Dana-Farber Cancer Institute Joseph O. Jacobson, M.D. Dana-Farber Cancer Institute Bruce E. Johnson, M.D. Dana-Farber Cancer Institute Philip W. Kantoff, M.D. Dana-Farber Cancer Institute Joel T. Katz, M.D. Brigham and Women’s Hospital Kenneth Kaushansky, M.D. Stony Brook University Ian E. Krop, M.D., Ph.D. Dana-Farber Cancer Institute Matthew H. Kulke, M.D. Dana-Farber Cancer Institute David J. Kuter, M.D., D.Phil. Massachusetts General Hospital Thomas J. Lynch, Jr., M.D. Yale Cancer Center Ursula A. Matulonis, M.D. Dana-Farber Cancer Institute Robert J. Mayer, M.D. Dana-Farber Cancer Institute Ellis Neufeld, M.D. Boston Children’s Hospital Peter E. Newburger, M.D. University of Massachusetts Medical School William K. Oh, M.D. Mount Sinai School of Medicine Geoffrey R. Oxnard, M.D. Dana-Farber Cancer Institute Ann H. Partridge, M.D., M.P.H. Dana-Farber Cancer Institute Geoffrey I. Shapiro, M.D., Ph.D. Dana-Farber Cancer Institute Lawrence N. Shulman, M.D. Dana-Farber Cancer Institute Robert J. Soiffer, M.D. Dana-Farber Cancer Institute David P. Steensma, M.D. Dana-Farber Cancer Institute Richard M. Stone, M.D. Dana-Farber Cancer Institute Sapna Syngal, M.D., M.P.H. Dana-Farber Cancer Institute Ayalew Tefferi, M.D. Mayo Clinic Eric P. Winer, M.D. Dana-Farber Cancer Institute Brian M. Wolpin, M.D. Dana-Farber Cancer Institute
  • 4. cancer medicine and hematology course schedule www.cme.hms.harvard.edu/courses/cancermedicine SATURDAY, SEPTEMBER 28, 2013 6:00 pm - 9:00 pm Evening Registration SUNDAY, SEPTEMBER 29, 2013 Presiding: Robert J. Mayer, M.D. 7:00 am Registration 8:45 am Welcome Robert J. Mayer, M.D. 9:00 am Stem Cell Biology and Hematopoietic Growth Factors David J. Kuter, M.D., D.Phil. 10:00 am Transfusion Medicine for the Clinician Walter H. Dzik, M.D. 11:00 am Break 11:15 am Hemolytic Anemias Jean M. Connors, M.D. 12:15 pm Bone Marrow Failure States Robert A. Brodsky, M.D., Ph.D. 1:15 pm Adjourn Presiding: David J. Kuter, M.D., D.Phil. 2:15 pm Thrombocytopenias Kenneth Kaushansky, M.D. 3:15 pm Iron Deficiency and Iron Overload Mark D. Fleming, M.D., Ph.D. 4:00 pm Break 4:15 pm Hemoglobinopathies Matthew M. Heeney, M.D. 5:15 pm Leukocyte Disorders Peter E. Newburger, M.D. 6:15 pm Adjourn MONDAY, SEPTEMBER 30, 2013 Presiding: James D. Griffin, M.D. 8:00 am Platelet Function and von Willebrand’s Disease Robert I. Handin, M.D. 9:00 am Hypercoagulable Syndromes and New Anticoagulant Therapies Kenneth A. Bauer, M.D. 10:15 am Break 10:30 am Hemophilia-Related Syndromes Ellis J. Neufeld, M.D., Ph.D. 11:30 am Panel Discussion 12:00 pm Adjourn Presiding: Bruce E. Johnson, M.D. 1:00 pm Molecular Genetics of Cancer Levi A. Garraway, M.D., Ph.D. 2:00 pm Advances in Cancer Drug Development Geoffrey I. Shapiro, M.D., Ph.D. 3:00 pm Break 3:15 pm Infections in the Immunocompromised Host Joel T. Katz, M.D. 4:00 pm Biology of Bone Marrow Transplantation Robert J. Soiffer, M.D. 5:00 pm Adjourn
  • 5. cancer medicine and hematology course schedule TUESDAY, OCTOBER 1, 2013 Presiding: Robert J. Soiffer, M.D. Acute Leukemia and Myelodysplasia: 8:00 am Biology David P. Steensma, M.D. 8:45 am Treatment Richard M. Stone, M.D. 9:45 am Chronic Myelogenous Leukemia Daniel J. De Angelo, M.D., Ph.D. 10:30 am Break 10:45 am Myeloproliferative Syndromes Ayalew Tefferi, M.D. 11:30 am Plasma Cell Neoplasms Kenneth C. Anderson, M.D. 12:30 pm Panel Discussion 1:00 pm Adjourn Presiding: Richard M. Stone, M.D. 2:00 pm Low Grade Lymphoma Jeremy S. Abramson, M.D. 2:40 pm High Grade Lymphoma Arnold S. Freedman, M.D. 3:30 pm Break 3:45 pm Hodgkin’s Disease George P. Canellos, M.D. 4:30 pm CLL and Variants John C. Byrd, M.D. 5:15 pm Panel Discussion 5:45 pm Adjourn 7:00 pm - 9:30 pm ABIM Maintenance of Certification (MOC) Session: 2013 Update in Medical Oncology Module Harold J. Burstein, M.D., Ph.D.; Daniel J. DeAngelo, M.D., Ph.D.; Robert J. Mayer, M.D. WEDNESDAY, OCTOBER 2, 2013 Presiding: Edward J. Benz, Jr., M.D. 8:00 am Neuroendocrine Tumors Matthew H. Kulke, M.D. Gastrointestinal Malignancies: 8:30 am Genetics and Screening Sapna Syngal, M.D., M.P.H. 9:00 am Esophageal and Gastric Charles S. Fuchs, M.D., M.P.H. 9:45 am Break 10:00 am Pancreas and Hepatobiliary Brian M. Wolpin, M.D. 10:45 am Colorectal and Anal Robert J. Mayer, M.D. 11:45 am Panel Discussion 12:15 pm Adjourn Presiding: Eric P. Winer, M.D. 1:15 pm Sarcoma and GIST George D. Demetri, M.D. 2:15 pm Mesothelioma and Thymic Tumors Geoffrey R. Oxnard, M.D. 3:00 pm Clinical Essentials of Palliative Care Janet L. Abrahm, M.D. 3:45 pm Break Gynecologic Cancer: 4:00 pm Ovarian Stephen A. Cannistra, M.D. 5:00 pm Cervical, Endometrial, Trophoblastic Ursula A. Matulonis, M.D. 5:45 pm Panel Discussion 6:15 pm Adjourn 8:00 pm - 10:00 pm Case Presentation Harold J. Burstein, M.D., Ph.D.; George P. Canellos, M.D.; Bruce E. Johnson, M.D.; David J. Kuter, M.D., D.Phil.; Robert J. Mayer, M.D.
  • 6. cancer medicine and hematology course schedule THURSDAY, OCTOBER 3, 2013 Presiding: Philip W. Kantoff, M.D. 8:00 am Melanoma F. Stephen Hodi, M.D. 9:00 am Thyroid Cancer Gilbert H. Daniels, M.D. 10:00 am Break 10:15 am Head and Neck Cancer Robert I. Haddad, M.D. Lung Cancer: 11:15 am Non-Small Cell Thomas J. Lynch, M.D. 12:10 pm Small Cell Bruce E. Johnson, M.D. 12:45 pm Panel Discussion 1:00 pm Adjourn Presiding: Lawrence N. Shulman, M.D. 2:00 pm Neuro-Oncology Tracy T. Batchelor, M.D., M.P.H. Genitourinary Cancer: 3:00 pm Testicular William K. Oh, M.D. 3:45 pm Break 4:00 pm Renal and Bladder Toni K. Choueiri, M.D. 4:45 pm Prostate Philip W. Kantoff, M.D. 5:45 pm Panel Discussion 6:15 pm Adjourn 7:00 pm - 10:00 pm Dinner at the Harvard Club “Does Quality Improvement Really Enhance Cancer Care?” - Joseph O. Jacobson, M.D. FRIDAY, OCTOBER 4, 2013 Presiding: Robert J. Mayer, M.D. Breast Cancer: 8:00 am Assessing Breast Cancer Risk and Opportunities for Breast Cancer Prevention Judy E. Garber, M.D., M.P.H. 8:30 am Advances in Staging, Prognosis, Surgery and Radiation Harold J. Burstein, M.D, Ph.D. 9:15 am Adjuvant and Neoadjuvant Therapy for Operable Breast Cancer Eric P. Winer, M.D. 10:00 am Break 10:15 am Management of Metastatic Disease: HER 2 Negative Disease Lawrence N. Shulman, M.D. HER 2 Positive Disease Ian E. Krop, M.D., Ph.D. 11:00 am Management and Counseling of Breast Cancer Survivors Ann H. Partridge, M.D., M.P.H. 11:30 am Panel Discussion 12:15 pm Concluding Remarks Robert J. Mayer, M.D. 12:30 pm Course Adjourn Please note: Program changes/substitutions may be made without notice. www.cme.hms.harvard.edu/courses/cancermedicine
  • 7. DISCLOSURE POLICY Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers, and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations. REFUND POLICY A handling fee of $60 is deducted for cancellation. Refund requests must be received by postal mail, email, or fax one week prior to this activity. No refunds will be made thereafter. COURSE LOCATION All sessions for this course will be held at The Fairmont Copley Plaza Hotel, 138 St. James Avenue, Boston MA 02116 (telephone: 617- 267-5300). ACCOMMODATIONS/TRAVEL A limited number of rooms have been reserved at The Fairmont Copley Plaza Hotel (telephone: 617-267-5300) until September 9, 2013. Please specify that you are enrolled in this course to receive a reduced room rate of $299 per night Single/ Double. Hotel arrangements can also be made online at:https://resweb.passkey.com/ go/danafarber2013. Please do not purchase non-refundable airline ticket(s) until you have received an email from our office confirming your paid registration. For airline reservations, contact the HMS Travel Desk toll free 1-877-4-HARVMD (1-877-442-7863), Monday – Friday, 9:00 AM to8:00 PM (EST). From outside the U.S., Canada, and Virgin Islands, please call 617-559-3764. cancer medicine and hemotology | September 29 – October 4, 2013 | course #331059 Tuition Fee: $1,500 (USD) Print Name Clearly – All Fields Required Full Name First Middle Initial Last Mailing Address Street City State Zip Code Daytime Phone ( ) Fax Number ( ) Please note: Your email address is used for critical information about the course, including registration confirmation, evaluation, and certificate. Please be sure to include an email address you check daily or frequently. Email Address  Please check if you wish to be excluded from receiving email notices of future Harvard Medical School – Department of Continuing Education programs. Profession Degree Primary Specialty (Physicians only) Board Certified: Yes No Professional School Attended (Physicians only) Harvard Medical School U.S. Medical School International Year of Graduation Register early as the course fills up quickly. www.cme.hms.harvard.edu/courses/cancermedicine cancer medicine and hematology Earn up to 51.75 AMA PRA Crategory 1 Credits™ cancer medicine and hematology Sunday, September 29 - Friday, October 4, 2013 ✁  Online registrants – add the first three characters of the source code found here Source code: J W E B K L M X Z Z Z REGISTRATION INFORMATION Tuition Fee — $1,500 (USD). Registration by credit card (VISA or MasterCard) can be made at: www.cme.hms.harvard.edu/courses/ cancermedicine. Registration by check (draft on a United States bank): please make payable to Harvard Medical School and mail with registration form to Harvard Medical School- Department of Continuing Education, PO Box 417476, Boston, MA 02241-7476. Telephone and fax registration is not accepted. Registration with cash payment is not permitted. Upon receipt of your paid registration, an email confirmation from the HMS-DCE office will be sent to you. Be sure to include an email address that you check frequently. Your email address is used for critical information including: registration confirmation, evaluation, and certificate. INQUIRIES By telephone: 617-384-8600, Monday – Friday, 10:00 AM to 4:00 PM (EST) or by email at: hms-cme@hms.harvard.edu ONLINE INFORMATION To register or view activity information online, visit www.cme.hms.harvard. edu/courses/cancermedicine. To ensure proper registration, please add the first three characters of the source code found at the bottom of this registration form.